Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma

Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma

Background: Fibroblast growth factor-23 (FGF-23) is a phosphaturic peptide and a key component of an endocrine feedback loop along with the hormonal vitamin D metabolite 1,25(OH) 2 D. Vitamin D has been shown to be inversely related to colorectal neoplasia; therefore, we hypothesized that the effect...

Full description

Bibliographic Details
Main Authors: Elizabeth Jacobs, Maria Elena Martinez, Julie Buckmeier, Peter Lance, Melissa May, Peter Jurutka
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Journal of Carcinogenesis
Subjects:
Adenoma
cancer
colorectal
fibroblast growth factor-23
fibroblast growth factor
Online Access:http://www.carcinogenesis.com/article.asp?issn=1477-3163;year=2011;volume=10;issue=1;spage=3;epage=3;aulast=Jacobs

Internet

http://www.carcinogenesis.com/article.asp?issn=1477-3163;year=2011;volume=10;issue=1;spage=3;epage=3;aulast=Jacobs

Similar Items